Shipping services continue despite COVID-19 outbreak ! Click here to view COVID-19 related products

LDN-193189

For research use only.

Catalog No.S2618 Synonyms: DM3189

129 publications

LDN-193189 Chemical Structure

CAS No. 1062368-24-4

LDN-193189 (DM3189) is a selective BMP signaling inhibitor, inhibits the transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 of 5 nM and 30 nM in C2C12 cells, respectively, exhibits 200-fold selectivity for BMP versus TGF-β.

Size Price Stock Quantity  
USD 110 In stock
USD 170 In stock
USD 570 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's LDN-193189 has been cited by 129 publications

Purity & Quality Control

Choose Selective TGF-beta/Smad Inhibitors

Biological Activity

Description LDN-193189 (DM3189) is a selective BMP signaling inhibitor, inhibits the transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 of 5 nM and 30 nM in C2C12 cells, respectively, exhibits 200-fold selectivity for BMP versus TGF-β.
Targets
ALK2 [1]
(C2C12 cells)
ALK3 [1]
(C2C12 cells)
5 nM 30 nM
In vitro

LDN193189 potently inhibits BMP4-mediated Smad1, Smad5 and Smad8 activation with IC50 of 5 nM, and efficiently inhibits transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 of 5 nM and 30 nM, respectively. Furthermore, LDN193189 also shows the inhibitory effect on the transcriptional activity induced by either constitutively active ALK2R206H or ALK2Q207D mutant proteins. [1] A recent study shows that LDN-193189 blocks the production of reactive oxygen species induced by oxidized LDL during atherogenesis in human aortic endothelial cells. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
C2C12 NF24OJNMcW6jc3WgRZN{[Xl? M2iyW4lvcGmkaYTzJJRp\SCtaX7hd4Uh[WO2aY\peJkhd2ZiQVzLOEBidmRiQXP0VmlKSSC5aYToJGlEPTEEoI\hcJVmeyCxZjCxNFEh[W6mIEKxNEBvdSxicnXzdIVkfGm4ZXz5 NXj0VYdURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWzOlg{OjJpPkK1N|Y5OzJ{PD;hQi=>
EOC216 MofSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV7JOJpUOC5zLUGwJO69VQ>? NEHtbGczNTFyIHS= NEnL[Y9FVVOR NHyycJlqdmS3Y3WgZ4VtdCCmZXH0bEBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldi=> NXnqRYJORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWyNlc5QTNpPkK1NlI4QDl|PD;hQi=>
OVAC429 NYnzZXMyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkT1Nk82KM7:TR?= MnfKOFghcA>? NXnFenZyTE2VTx?= MkC4[IVkemWjc3XzJJRp\SCyZYLj[Y51[WenIH;mJINmdGy|IHnuJHMheGijcx?= Mn\0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{Mke4PVMoRjJ3MkK3PFk{RC:jPh?=
SKOV3 M3XzcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mkm3Nk82KM7:TR?= M{XIelQ5KGh? M{jlV2ROW09? NWjrSmZ3\GWlcnXhd4V{KHSqZTDw[ZJk\W62YXflJI9nKGOnbHzzJIlvKFNicHjhdy=> MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTJ{N{i5N{c,OjV{Mke4PVM9N2F-
OVCA429 NVTrNGFpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnnONk82KM7:TR?= Ml;mOFghcA>? M3fRfmROW09? NEWxcGNl\WO{ZXHz[ZMhfGinIIDldoNmdnSjZ3Wgc4Yh[2WubIOgbY4hWyCyaHHz NXLa[ppRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWyNlc5QTNpPkK1NlI4QDl|PD;hQi=>
EOC219 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1fZS|IwPSEQvF2= NITseJc1QCCq MYXEUXNQ M{nBcYRm[3KnYYPld{B1cGVicHXyZ4VvfGGpZTDv[kBk\WyuczDpckBUKHCqYYO= NXfCOFk1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWyNlc5QTNpPkK1NlI4QDl|PD;hQi=>
A549 M4q1TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlS2NE42NTF4IN88US=> MXLEUXNQ NWDFUpZEcW6qaXLpeJMh[2WubDDndo94fGhiaX6gZUBld3OnLXTldIVv\GWwdDDtZY5v\XJ? MkCyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5N{iwNVEoRjJ2N{e4NFEyRC:jPh?=
BEAS-2B  NVe3elRkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEmzfHUxNjVvMU[g{txO NVfETHQyTE2VTx?= M{\OPYlvcGmkaYTzJINmdGxiZ4Lve5RpKGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz M1nOZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{e4NFEyLz5{NEe3PFAyOTxxYU6=
hBMSCs NYDm[4RLTnWwY4Tpc44hSXO|YYm= MVqwMlLDqM7:TR?= NWq3bZRGPyCm MoH3ZYJwdGm|aHXzJJRp\SC|aXzpZolvcW5vcILvcY91\WRiQVzQJIFkfGm4aYT5xsBx[XK2bIm= NV\rSHRMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSwO|YyQDdpPkK0NFc3OTh5PD;hQi=>
PANC-1 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4DJSlUuPTByIH7N NHvNbIM1QCCq Mmn0bY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZI> MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzl4OUeyPUc,OjN7Nkm3Nlk9N2F-
MIA PaCa-2 Mo\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLjRpE1PS13MECgcm0> NVfhTYk6PDhiaB?= MnHPbY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZI> M1zMfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|OU[5O|I6Lz5{M{m2PVczQTxxYU6=
Bx-PC3 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1f4blUuPTByIH7N NFHiblE1QCCq NWXwbI1wcW6qaXLpeJMh[2WubDDndo94fGhiaX6gZUBld3OnLXTldIVv\GWwdDDtZY5v\XJ? NUHMZmx4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5Olk4OjlpPkKzPVY6PzJ7PD;hQi=>
PC3  NH3vc|JHfW6ldHnvckBCe3OjeR?= NYPhRnNmPTByIH7N MY[yJIg> M1mxR5JmeHKnc4Pld{Bi[3SrdnH0bY9vKG:oIGPtZYQyNzVxODDhcoQhWC2VbXHkN{Bt\X[nbIO= MnLSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ2NUK4PFMoRjJ{NEWyPFg{RC:jPh?=
LNCaP NU[zXYdVTnWwY4Tpc44hSXO|YYm= NF7UdVAx6oDVNUCwJI5O NIToV48zKGh? M2K1eZJmfmW{c3XzJJJieGGveXPpck1qdmS3Y3XkJINmdGxiZHXheIg> MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjR3Mki4N{c,OjJ2NUK4PFM9N2F-
EOC NHf3OHNHfW6ldHnvckBCe3OjeR?= NGPvcnEyOC1zMECwJI5O NVrMVmZlPzJiaB?= NFXoWG5z\WS3Y3XzJJRp\SCyaH;zdIhwenmuYYTl[EBDVVBiUj3TcYFlOS93L{lCpC=> Mnj1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ{NEm0NVUoRjJ{MkS5OFE2RC:jPh?=
HaCaT  MUHGeY5kfGmxbjDBd5NigQ>? MVmwMlAxOS1zMDFOwG0> NXTBXXA{OiCq NWHoPXNTcW6qaXLpeJMhSk2SMj3pcoR2[2WmIIDoc5NxcG:{eXzheIlwdiCxZjDTcYFlOS93L{ige4l1cCCjbjDJR|UxyqCxZjD+NE4xODYEoN88US=> MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTd2MEm2Okc,OjF5NEC5OlY9N2F-
HaCaT  MlzoSpVv[3Srb36gRZN{[Xl? MoLNNE4xODFvMUCg{txO M2jsNFIhcA>? NHTXO|lqdmirYnn0d{B1cGViYXLpcIl1gSCxZjDBUGszKHSxIIDoc5NxcG:{eXzheIUhT1OWLWPtZYQyyqC5aYToJIFvKEmFNUFCpI9nKDR3wrDuUS=> M4LxPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzN{SwPVY3Lz5{MUe0NFk3PjxxYU6=
HaCaT  NIrRVGRHfW6ldHnvckBCe3OjeR?= NVz1PVhKOC5yMEGtNVAh|ryP M33JWVIhcA>? NVjN[pZFcW6qaXLpeJMhfGinIHHibYxqfHlib3[gRWxMOyC2bzDwbI9{eGixconsZZRmKFOvYXSxxsB4cXSqIHHuJGlEPTEEoH;mJFExOCCwTR?= M1ftRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzN{SwPVY3Lz5{MUe0NFk3PjxxYU6=
HaCaT  MUfGeY5kfGmxbjDBd5NigQ>? MUWwMlAxOS1zMDFOwG0> M1XsZVIhcA>? NYrpcYFRcW6qaXLpeJMhSUyNNDDhcoQhSUyNNTD3bZRpKEmFNUFCpJZidHWnczDv[kAxNjQEoN88UUBidmRiMD61xsDPxE1icnXzdIVkfGm4ZXz5 M{\Ic|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzN{SwPVY3Lz5{MUe0NFk3PjxxYU6=
C2C12 M3nKTGZ2dmO2aX;uJIF{e2G7 Mo\TN|AhdWmwcx?= MnLETY5pcWKrdHnvckBw\iCETWC2MYlv\HWlZXSgRWxMOiC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkhcW5ibX;1d4UhSzKFMUKgZ4VtdHNiZYjwdoV{e2mwZzDCVmUuVHWlIHHmeIVzKDNyIH3pcpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyIE2gNE4xOTRizszNMi=> MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODJ{N{m0Okc,OzB{Mke5OFY9N2F-
BT-12 M2LLdZFJXFNiYYPzZZk> MnTkdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEKWLUGyJINmdGy| M4e0e|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
fibroblast cell MX3xTHRUKGG|c3H5 M33qPZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiClb370do9tKEiqIIfpcIQhfHmyZTDmbYJzd2KuYYP0JINmdGy| M3jzNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh30 MkPydWhVWyCjc4PhfS=> M{m4dpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCUaEOwJINmdGy| MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
KB-3-1 MWfGeY5kfGmxbjDhd5NigQ>? MVXQMYdtgWOxcILveIVqdiC|dXLzeJJifGW|IHnk[Y51cW[rZXSgbY4hU0JvMz2xJIFl\W6xY3HyZ4lvd22jIHPlcIwhdGmwZTygdWhVWyC2aHXyZZBmfXSrYzDsbYJz[XK7IIPjdoVmdg>? NG\hOnI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUWxOVI5PCd-M{G1NVUzQDR:L3G+
C2C12 MlLxSpVv[3Srb36gZZN{[Xl? M1T2OlAvOSC3TR?= MVzJcohq[mm2aX;uJI9nKEGOS{WgbY4hdW:3c3WgR|JEOTJiY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gWGdH[mW2YUGtbY5lfWOnZDDTcYFlOS93IIDoc5NxcG:{eXzheIlwdiCjdDCwMlEhfU1iYomgW4V{fGW{bjDicI91KG2ndHjv[C=> MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDFyM{CyOUc,OjhzMEOwNlU9N2F-

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
pSMAD1 / pSMAD5 / pSMAD8 / SMAD1 / SMAD5 / SMAD8 / ID1 / SMAD4 / PARP / Cleaved PARP; 

PubMed: 31098401     


In vitro molecular pharmacology of LDN-193189 and LDN-214117. Western blot analysis of time- and concentration-dependent effects on downstream signalling in response to a LDN-193189 and b LDN-214117 in DIPG cells. Increasing concentrations (0–10 µM) at 4 and 8 h are shown for SU-DIPG-VI, HSJD-DIPG-IV and HSJD-DIPG-007. GAPDH is the loading control.

31098401
Immunofluorescence
Tbx18 / Hcn4; 

PubMed: 30906456     


Representative immunofluorescence microscopy images of epicardial progenitor cells from the four groups with staining for Hcn4 (red). The nuclei were counterstained with DAPI (blue) and the YFP expressed by the cells is apparent (scale bar, 50 µm). (Tbx18 was conjugated to YFP).

30906456
Growth inhibition assay
Cell viability; 

PubMed: 31098401     


Screening of ALK2 inhibitors in vitro. Concentration-response curves for eight ALK2 inhibitors tested against three ACVR1 mutant cell cultures (HSJD-DIPG-007 (R206H), SU-DIPG-IV (G328V), HSJD-DIPG-018 (R258G), purple) and two wild-type cultures (SU-DIPG-VI, QCTB-R059, grey). a Pyrazolo[1,5-a]pyrimidines—dorsomorphin, LDN-193189, DMH1, LDN-212854. b Pyridines—K02288, LDN-214117, LDN-213844, LDN-213819. Concentration of compound is plotted on a log scale (x-axis) against cell viability (y-axis). Mean plus standard deviation are plotted from at least n = 3 experiments.

31098401
In vivo In conditional caALK2-transgenic mice with Ad.Cre on on postnatal day 7 (P7), LDN-193189 (3 mg/kg i.p) leads to mild calcifications surrounding the left tibia and fibula first visible at P13, and prevents radiographic lesions at P15 without causing weight loss or growth retardation, spontaneous fractures, decreased bone density or behavioral abnormalities. [1] LDN193189 dorsalizes zebrafish embryos by inhibiting signaling pathways induced by bone morphogenetic protein (BMP)6 without effect on vascular development. [2] In PCa-118b tumor-bearing mice, LDN-193189 treatment attenuates tumor growth and reduces bone formation in the tumors. [3] In LDL receptor-deficient (LDLR-/-) mice, LDN-193189 potently inhibits development of atheroma. Moreover, LDN-193189 also exhibits the inhibitory effects on associated vascular inflammation, osteogenic activity, and calcification. [4]

Protocol

Animal Research:[1]
- Collapse
  • Animal Models: Ad.Cre on P7 is injected into conditional caALK2–transgenic and wild-type mice.
  • Dosages: ≤3 mg/kg
  • Administration: Administered via i.p.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO Insoluble
Water Insoluble
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 406.48
Formula

C25H22N6

CAS No. 1062368-24-4
Storage powder
in solvent
Synonyms DM3189
Smiles C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

TGF-beta/Smad Signaling Pathway Map

TGF-beta/Smad Inhibitors with Unique Features

Related TGF-beta/Smad Products

Tags: buy LDN-193189 | LDN-193189 supplier | purchase LDN-193189 | LDN-193189 cost | LDN-193189 manufacturer | order LDN-193189 | LDN-193189 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID